Endocrine Tumor
Conditions
Keywords
Endocrine Tumor, Reference centre, rare diseases, transcriptoms
Brief summary
To allow the identification of markers, it is necessary to extend research networks more widely to collect and properly explore aggressive pituitary tumours. The multidisciplinary consultation meeting (RCP), organised by the reference centre for rare diseases of the pituitary gland, dedicated to aggressive pituitary tumours and carcinomas (HYPOcare), which is unique in France and brings together national experts, currently makes it possible to orientate the management of patients with an aggressive pituitary tumour. With more than 80 patient files discussed since its inception, the patient cohort via the HYPOcare RCP is one of the largest both nationally and internationally. At present, this data source is only dedicated to the clinical management of the files without the possibility of carrying out research work
Interventions
None listed
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Inclusion Criteria : * Patients with a diagnosis of pituitary tumour * Patients whose file has been presented to the national HYPOcare RCP *
Exclusion criteria
: * Patients objecting to participating in this research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Characterisation of aggressiveness of pituitary tumours by tanscriptome analysis | 3 years | Molecular and transcriptomic signature of aggressiveness of pituitary tumours predictive of prognosis |
Countries
France
Outcome results
None listed